Top Markets
#1 Black Phoenix Black Phoenix +826.83%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.73%
#3 Beam Beam +24.43%
#4 Tutorial Tutorial +24.34%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +21.60%
#6 SAFEcoin SAFEcoin +20.63%
#7 Bless Bless +17.83%
#8 THORChain THORChain +16.01%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +15.60%
#10 EfficientFrontier EfficientFrontier +14.37%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Lin BioScience, Inc. Lin BioScience, Inc.

Lin BioScience, Inc.

6696
Rank in Stocks #5730
Lin BioScience, Inc. is an innovative biopharmaceutical company focused on... Lin BioScience, Inc. is an innovative biopharmaceutical company focused on developing novel therapies across oncology, ophthalmology, and metabolic diseases. Its robust pipeline includes LBS-008, an orally administered treatment currently in Phase 3 clinical trials for adolescent Stargardt disease (STGD1) and Phase 2/3 trials for dry age-related macular degeneration (Dry AMD), both aimed at evaluating its safety and effectiveness. Other key candidates are LBS-007, a natural non-ATP CDC7 inhibitor designed to combat various cancers; LBS-002, an anti-tubulin compound targeting primary and metastatic brain tumors; and LBS-009, an oral medication for non-alcoholic fatty liver disease and Type 2 diabetes. The company is headquartered in Taipei, Taiwan.
Share Price
$29.86
Last synced: 2026-08-19
Market Cap
$2.48B
Change (1 day)
4.92%
Change (1 year)
502.82%
Country
TW
Trade Lin BioScience, Inc. (6696)

Category

Healthcare
Operating Margin for Lin BioScience, Inc. (6696)
Operating Margin as of 2026 TTM: 0.00%
According to Lin BioScience, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Lin BioScience, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.72% -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.